1. India Stocks

  2. •

    Basic Materials

  3. •

    Agricultural Inputs
Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited

NATHBIOGEN.NS
Nath Bio-Genes (India) LimitedIN flagNational Stock Exchange of India
164.76
INR
+1.96
- -
3.13BMarket Cap
Nath Bio-Genes (India) Limited
NATHBIOGEN.NS
(National Stock Exchange of India)

Recent

price

164.76

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
77.43
86.04
107.55
115.8
101.29
106.09
112.79
121.32
147.28
161.73
146.47
158.58
175.03
190.4
224.31
231.77
Revenue per Share
5.75
7.34
15.19
15.87
8.85
10.17
17.31
20.22
26.56
29.29
-35.46
18.42
20.85
20.14
20.98
21.68
Basic EPS, GAAP
- -
-4.46
7.58
3.26
-12.92
-0.49
-30.51
-23.8
-3.54
-5.52
8.38
18.85
25.16
5.04
-7.85
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
2
1.98
1.92
- -
Dividend per Share
18.82
26.16
41.34
57.19
169.6
179.77
188.41
188.63
215.19
244.48
207.03
223.46
242.31
258.42
9.58
9.9
Book Value per Share
19.2
28.64
45.92
63.86
178.08
189.52
273.82
265.2
285.44
315.54
278.83
296.13
316.31
332.47
340.11
351.42
Tangible Book Value per Share
16
16
16
16
16
16
17
19
19
19
19
19
19
19
20
19
Basic Weighted Avg Shares
1,239
1,377
1,721
1,853
1,621
1,698
1,916
2,306
2,799
3,073
2,784
3,014
3,326
3,649
4,451
4,451
Sales/Revenue/Turnover
9.85
11.5
16.9
16.46
13.15
15.74
20.96
18.31
19.11
20.97
12.43
15.28
14.08
12.6
10.89
10.89
Operating Margin (%)
47
45
47
44
39
30
10
14
15
28
62
60
65
38
40
40
Depreciation Expense
92
117
243
254
142
163
294
384
505
557
-674
350
396
386
416
416
Net Income, GAAP
- -
4.48
4.74
3.63
6.04
2.81
2.12
1.12
- -
1.92
- -
3.19
4.68
4.96
10.09
10.09
Effective Tax Rate (%)
7.42
8.53
14.12
13.7
8.74
9.59
15.35
16.67
18.04
18.11
-24.21
11.62
11.91
10.58
9.35
9.35
Profit Margin (%)
242
359
542
814
965
1,121
2,544
2,711
3,027
3,631
2,735
3,034
3,092
3,247
3,842
3,842
Working Capital
8
12
14
7
150
201
3
5
3
7
7
4
49
130
173
173
LT Debt
457
575
818
1,071
2,870
3,033
4,692
5,076
5,576
6,133
5,419
5,732
6,099
6,444
6,805
6,805
Total Equity
- -
23.31
31.15
25.46
8.45
7.18
8.93
7.83
- -
9.43
- -
6.85
6.45
5.96
5.54
5.54
Return on Invested Capital (%)
- -
23.83
37.96
29.5
8.79
7.28
10.95
11.26
- -
12.14
- -
8.71
8.69
8.17
14.45
14.45
Return on Capital (%)
- -
32.63
44.99
32.21
7.81
5.82
9.68
11.33
13.16
12.74
-15.71
8.56
8.95
8.08
16.19
16.19
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
1,406
- -
1,212
LT Borrowings
142
- -
173
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
19
- -
19
Market Capitalization
3,165
2,986
2,478

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
7,064
- -
7,789
Cash, Cash Equivalents & STI
1,589
- -
2,394
Accounts Receivable, Net
1,794
- -
854
Inventories
3,080
- -
4,505
Total Current Liabilities
3,166
- -
3,947
Payables & Accruals
- -
- -
- -
ST Debt
1,406
- -
1,212
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.02%
2.36%
5.6%
Free Cash Flow
593.2%
-86.93%
-261.25%
Net Income, GAAP
-18.67%
-70.92%
7.85%
Sales/Revenue/Turnover
11%
8.18%
21.98%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,353
226
317
430
3,326
2025
2,439
322
369
520
3,649
2026
2,837
438
660
516
4,451

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
17.47
0.79
0.69
- -
20.85
2025
17.49
0.53
1.39
0.78
20.14
2026
19.58
1.4
0.84
- -
20.98

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
2
2025
- -
- -
- -
- -
1.98
2026
- -
- -
- -
- -
1.92
Similar Companies
Adecoagro S.A. (0DWL.L)
Amira Nature Foods Ltd. (ANFIF)
Kaveri Seed Company Limited (KSCL.NS)
DONGBANG AGRO Corporation (007590.KS)
Bansisons Tea Industries Ltd. (BANSTEA.BO)
CVR Partners, LP (UAN)
Business
Nath Bio-Genes (India) Limited engages in the research, development, production, processing, and marketing of BT cotton, hybrid, and varietal seeds for field crops, vegetables, oilseeds, fiber crops, and forage; it also offers plant nutrition supplements including WINPro GOLii, WINall, Win Chin Win, WINALL granules, and WINPRO GOLI, as well as forage products such as NUTRIMAX and NUTRIMAX GOLD. The company operates primarily in India through approximately 16 business centers covering 131 territories and over 2,000 distributors, with emerging international presence including a joint venture, Nath Bio-Genes CA LLC in Uzbekistan incorporated in 2025 holding a 90% stake, and advancements in the Philippines; it sources seed production from over 30,000 acres leased from 25,000 growers nationwide. Founded in 1979 as part of the Nath Group by Nandkishor Kagliwal and headquartered in Aurangabad, Maharashtra, Nath Bio-Genes supports farmers via over 500 Nath Farmer Advisors delivering extension services like crop demonstrations, agronomic guidance, and post-harvest training to approximately 200,000 farmers. Recent developments include the launch of four new hybrid paddy varieties, Dhoom, Dhadak, and Dhadak Gold, alongside two new organic fertilizers, WINALL granules and WINPRO GOLI, in 2023-24 to enhance soil nutrition; the company reports robust Q2FY26 financials with 23.5% revenue growth to Rs 398 million, 45.4% profit after tax increase to Rs 42 million, expanded gross margins to 68%, and strong vegetable seeds segment growth of 24.4%, complemented by successful Uzbekistan joint venture operations.